Our research strategy
Over the next 5 years, we want to invest over £1 million into research to improve early diagnosis for pancreatic cancer.
Currently, 80% of patients face a terrible prognosis as they have had their disease diagnosed at a late stage, which is why survival rates are so low. We need to change this and get people diagnosed in time for resectional surgery – currently the only potential for a cure.
At the moment, those people diagnosed in time for resectional surgery have a chance of surviving five years that is ten times greater than those who are not diagnosed in time for surgical removal.
Our research strategy over the next 5 years is to research and support research into the early diagnosis of pancreatic cancer.
- Not to duplicate existing efforts either in the UK or World-wide
- Have an open application policy to attract researchers with an interest in pancreatic cancer
- Use Independent Peer Review to evaluate and monitor all funding decisions
- Have a clear focus on potential outcomes and impact of our research
- Collaborate with other UK funders of pancreatic cancer research to maximise our investment.